Comments
Testing time for Roche's breast cancer business
05.09.2012. | LONDON (Reuters) - Roche Holding AG, the world's biggest maker of cancer drugs, faces a testing time in its breast cancer business as a near-term threat to Herceptin, its third-biggest seller, could take the shine off the long-term promise of its new medicines....
